for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-WLVBP Says Capsida Announced Multi-Year Collaboration, Option Agreement With Abbvie

April 29 (Reuters) -

* WESTLAKE VILLAGE BIOPARTNERS, VERSANT VENTURES ANNOUNCE LAUNCH OF GENE THERAPY COMPANY CAPSIDA BIOTHERAPEUTICS WITH $50 MILLION SERIES A FINANCING

* WLVBP-DEAL WITH ABBVIE GIVES CAPSIDA $90 MILLION UP FRONT & EQUITY INVESTMENT CAPITAL TO CREATE TISSUE-TARGETED GENE THERAPIES FOR 3 CNS DISEASE TARGETS

* WLVBP- CAPSIDA ELIGIBLE TO RECEIVE UPTO HIGH SINGLE-DIGIT ROYALTY PAYMENTS ON FUTURE PRODUCT SALES FROM ABBVIE COLLABORATION

* WLVBP SAYS CAPSIDA ANNOUNCED MULTI-YEAR COLLABORATION, OPTION AGREEMENT WITH ABBVIE Source text : refini.tv/2Se8nwP

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up